ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study.
Jun LiMohamed MoustafaMichael LineckerGeorg LurjeIvan CapobiancoJanine BaumgartFrancesca RattiFalk RauchfussDeniz BalciEduardo FernandesRoberto MontaltiRicardo Robles-CamposBergthor BjornssonStefan A ToppJiri FronekChao LiuRoger WahbaChristiane BrunsStefan M BrunnerHans J SchlittAsmus HeumannBjörn-Ole StübenJakob R IzbickiJan BednarschEnrico GringeriElisa FasoloJens RolingerJakub KristekRoberto Hernandez-AlejandroAndreas SchnitzbauerNatascha NuesslerMichael R SchönSergey VoskanyanAthanasios S PetrouOszkar HahnYuji SoejimaEmilio VicenteCarlos Castro-BenitezRené AdamFederico TomassiniRoberto Ivan TroisiAlexandros KantasKarl Juergen OldhaferVictoria ArdilesEduardo de SantibanesMassimo MalagoPierre-Alain ClavienMarco VivarelliUtz SettmacherLuca AldrighettiUlf NeumannHenrik PetrowskyUmberto CilloHauke LangSilvio NadalinPublished in: Annals of surgical oncology (2020)
ALPPS showed high efficacy in achieving R0 resections in locally advanced ICC. To get the most oncological benefit from this aggressive surgery, ALPPS would be restricted to patients with single lesions and sufficient FLR2.